Hensley Mark Earl bought HRTX
August 6, 2026 · Form 4 insider transaction
Hensley Mark Earl bought 31,250 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,250
Price
N/A
Total value
N/A
InsiderHensley Mark Earl
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 6, 2026
Filing dateAugust 10, 2026
Shares owned after179,789
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock.